4.7 Article

Protein delivery based on uncoated and chitosan-coated mesoporous silicon microparticles

期刊

COLLOIDS AND SURFACES B-BIOINTERFACES
卷 88, 期 2, 页码 601-609

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.colsurfb.2011.07.049

关键词

Porous silicon; Electrochemical pore formation; Chitosan; Insulin; BSA; Proteins; Controlled drug delivery

资金

  1. IMPIVA [IMIDTP/2009/152]
  2. MICINN [PTQ-09-01-00836]
  3. Xunta de Galicia [PGIDIT07PXIB203067PR]
  4. Project BioNanoSmart-DDS [908111]
  5. Conselleria de Innovacion e Industria
  6. Spanish Ministry of Science and Innovation [PS09/01786]

向作者/读者索取更多资源

Mesoporous silicon is a biocompatible, biodegradable material that is receiving increased attention for pharmaceutical applications due to its extensive specific surface. This feature enables to load a variety of drugs in mesoporous silicon devices by simple adsorption-based procedures. In this work, we have addressed the fabrication and characterization of two new mesoporous silicon devices prepared by electrochemistry and intended for protein delivery, namely: (i) mesoporous silicon microparticles and (ii) chitosan-coated mesoporous silicon microparticles. Both carriers were investigated for their capacity to load a therapeutic protein (insulin) and a model antigen (bovine serum albumin) by adsorption. Our results show that mesoporous silicon microparticles prepared by electrochemical methods present moderate affinity for insulin and high affinity for albumin. However, mesoporous silicon presents an extensive capacity to load both proteins, leading to systems were protein could represent the major mass fraction of the formulation. The possibility to form a chitosan coating on the microparticles surface was confirmed both qualitatively by atomic force microscopy and quantitatively by a colorimetric method. Mesoporous silicon microparticles with mean pore size of 35 nm released the loaded insulin quickly, but not instantaneously. This profile could be slowed to a certain extent by the chitosan coating modification. With their high protein loading, their capacity to provide a controlled release of insulin over a period of 60-90 min, and the potential mucoadhesive effect of the chitosan coating, these composite devices comprise several features that render them interesting candidates as transmucosal protein delivery systems. (C) 2011 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据